Investment Rating - The report maintains an "OUTPERFORM" rating for the company [3][7]. Core Insights - Leapmotor achieved a record-high gross margin of 14.9% in Q1 2025, with revenue reaching RMB 10.02 billion, reflecting a year-on-year growth of 187.1% driven by a 162% increase in vehicle deliveries and improved product mix [4][12]. - The company significantly narrowed its net loss to RMB 130 million, outperforming market expectations due to margin expansion outpacing operating expense growth [12][4]. - Leapmotor's domestic deliveries soared to 87,552 units in Q1 2025, up 162.1% year-on-year, with plans for further expansion in both domestic and international markets [5][13]. Financial Performance Summary - Revenue projections for Leapmotor are RMB 67.6 billion in 2025, RMB 81.2 billion in 2026, and RMB 102.5 billion in 2027, with net profits expected to be RMB 0.6 billion, RMB 3.5 billion, and RMB 6.0 billion respectively [7][15]. - The gross profit margin is expected to improve from 14.0% in 2025 to 18.1% in 2027, indicating a positive trend in profitability [10][15]. - The company has a strong cash position with RMB 25.7 billion in cash as of March 31, 2025, supporting its growth initiatives [12][4]. Market Position and Strategy - Leapmotor's new C10 model features significant upgrades, including a 12% increase in range and enhanced driving dynamics, which are expected to strengthen its competitive position in the market [6][14]. - The company plans to increase its sales outlets and service centers, aiming for a 90% coverage in prefecture-level cities by the end of 2025 [5][13]. - Leapmotor's strategy focuses on a closed-loop business model that leverages scale to reduce costs and enhance market share, driving further product iterations and competitiveness [6][14].

Investment Rating - The report maintains a "Buy" rating for Leapmotor, indicating a potential return exceeding 15% over the next 12 months [4][18]. Core Insights - Leapmotor's Q1 2025 net loss of RMB 130 million exceeded previous expectations, driven by an increase in average selling price (ASP) and gross profit margin (GPM), along with unexpected contributions from strategic partnerships [1][2]. - The sales volume forecast for FY25 has been raised by 15% to 550,000 units, reflecting strong sales performance and order volume from April to May [3][4]. - The GPM for Q1 2025 improved by 1.6 percentage points to 14.9%, attributed to strategic cooperation with FAW and effective cost reduction efforts [2][3]. Financial Performance Summary - Revenue projections for FY25 have been increased to RMB 58.993 billion, with a year-on-year growth rate of 83.4% [5][13]. - The net profit forecast for FY25 has been adjusted from a loss of RMB 98 million to a profit of RMB 118 million, with significant profit growth expected in FY26 [4][13]. - The GPM for FY25 is now projected at 12.1%, up from 11.2%, reflecting enhanced cost management capabilities [3][13]. Valuation and Target Price - The target price has been raised from HKD 50.00 to HKD 72.00, based on a price-to-sales ratio of 1.5 times for FY25 [4][6]. - The report highlights a significant improvement in market sentiment and profit outlook for Leapmotor, supporting the revised target price [4][6]. Shareholder Structure - Major shareholders include Mr. Jiangming Zhu with 25.0% and Stellantis N.V. with 21.3% [7]. Stock Performance - Leapmotor's stock has shown strong performance, with a 1-month absolute return of 38.4% and a 6-month return of 106.3% [8].

Investment Rating - The report maintains an "Outperform" rating for Gushengtang, with a target price of HKD 67.35 per share, reflecting a strong growth outlook [2][5]. Core Insights - The number of medical visits in Q1 2025 increased by 12.7% year-on-year, reaching approximately 1.21 million, although the growth rate has slowed compared to the previous year [3][10]. - The company is expected to see significant performance contributions in 2025 from mergers and acquisitions (M&A), artificial intelligence (AI), and in-hospital preparations [4][11]. Summary by Sections Financial Performance - Revenue projections for 2025 and 2026 are RMB 3.79 billion and RMB 4.63 billion, respectively, indicating year-on-year growth of 25.3% and 22.2% [5][11]. - Adjusted net profit is forecasted at RMB 480 million for 2025 and RMB 580 million for 2026, with growth rates of 20.6% and 21.0% [5][11]. - The gross profit margin is expected to remain stable at 30.1% across the forecast period [5]. Growth Drivers - The company has signed equity transfer agreements with four domestic targets in Q1 2025, with an average valuation of 0.8-1x PS, indicating attractive acquisition opportunities [4][13]. - An AI initiative to launch digital twins of renowned TCM doctors is expected to contribute RMB 30 million in annual performance starting in July 2025 [4][13]. - Plans to introduce 10 new in-hospital preparations in 2025 are anticipated to generate over RMB 50 million in revenue [4][13]. Market Position - Gushengtang is recognized as a leading domestic chain in traditional Chinese medical services, benefiting from strong brand power and resilient performance [5][11]. - The company has a market capitalization of HKD 7.95 billion (approximately USD 1.02 billion) and a free float of 62% [2].

Investment Rating - The report assigns a "Buy" rating for China Feihe (06186.HK) for the first time [1]. Core Views - The company is positioned as a leading domestic infant formula producer, with a significant turnaround in performance expected in 2024 due to channel reforms and a focus on high-end products [8]. - The company has a strong cash position and plans to increase its dividend payout ratio to 76% in 2024, highlighting its commitment to shareholder returns [8]. - The infant formula industry is anticipated to rebound, driven by a recovery in birth rates and a sustained trend towards premiumization [8]. Summary by Sections 1. High Dividend and Performance Turnaround - China Feihe is one of the earliest milk powder companies in China, focusing on infant formula and maintaining a leading market share [14]. - The company has experienced a significant decline in performance from 2021 to 2023 but is expected to show improvements in 2024, with revenue and net profit projected to grow by 6.2% and 5.3% respectively [20][19]. - The company’s dividend payout ratio has increased from 40.2% in 2019 to 76% in 2024, indicating a strong focus on returning value to shareholders [32]. 2. Strategic Focus on Premium Products and Channel Management - The company has shifted its focus to high-end products, with the ultra-premium "Xing Fei Fan" series accounting for 75% of its infant formula revenue in 2024, up from 22% in 2016 [8][36]. - Marketing strategies include high-profile promotions and enhanced consumer engagement, leading to a strong brand presence in the market [49]. - The company has improved its channel management, particularly in the maternal and infant sectors, and has expanded its online presence post-pandemic [8]. 3. Industry Demand Recovery and Market Position - The infant formula market in China is expected to see a marginal recovery, with a projected decline of only 1.2% in 2025, influenced by a rebound in birth rates [8]. - China Feihe holds a 17.5% market share in the infant formula sector, indicating room for growth compared to international competitors [8]. - The company is enhancing its channel control and product offerings, particularly with the "Xing Fei Fan" series, which is expected to drive revenue growth and improve profit margins [8]. 4. Financial Forecast and Valuation - Revenue forecasts for China Feihe are projected at 221.7 billion, 236.3 billion, and 251.7 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 38.7 billion, 43.0 billion, and 47.3 billion yuan [1]. - The company’s price-to-earnings ratio is expected to decrease from 13x in 2025 to 10x in 2027, indicating a potentially undervalued stock compared to peers [8].

Investment Rating - The report assigns a positive investment rating to Tencent Holdings (00700.HK), indicating a potential upside in the stock price of approximately 20%-50% from the current levels, with a target price range of HKD 600-750 [27]. Core Insights - Tencent's Q1 2025 financial results exceeded market expectations, with total revenue reaching RMB 1800.22 billion, a year-on-year increase of 13%, and adjusted net profit of RMB 613.29 billion, up 22% year-on-year [2][27]. - The company's strong performance is driven by its leading position in domestic gaming and significant growth in international markets, alongside robust contributions from high-margin businesses such as advertising and cloud services [2][27]. - Tencent's strategic focus on AI technology is enhancing operational efficiency and driving revenue growth across various segments, including gaming and advertising [27]. Financial Performance - In Q1 2025, Tencent achieved a core net profit margin of 26.5% and a gross profit margin of 56%, both reaching historical peaks [2][5]. - The company reported a free cash flow of RMB 471 billion and maintained a strong cash reserve of RMB 2052.53 billion, reflecting a healthy financial position [5][27]. - Capital expenditures surged by 91% year-on-year to RMB 274.8 billion, primarily for AI-related infrastructure and model development [5][8]. Gaming Business - Tencent's value-added services revenue grew by 17% year-on-year, with domestic gaming revenue increasing by 24% to RMB 429 billion, driven by record-breaking performances of titles like "Honor of Kings" and "Peacekeeper Elite" [9][10]. - International gaming revenue reached RMB 166 billion, up 23% year-on-year, contributing 27.9% to total gaming revenue [10][27]. - The integration of AI technology in gaming operations has improved efficiency, with a 40% increase in scene building efficiency and enhanced player experiences through AI-driven features [12][15][16]. Advertising Business - Tencent's marketing services revenue rose by 20% year-on-year to RMB 318.53 billion, driven by explosive growth in video account advertising [18][27]. - The advertising segment is transitioning from "traffic monetization" to "technology empowerment," with significant contributions from AI-driven advertising systems [18][20]. - The company is optimizing its advertising structure, leading to improved conversion rates and increased user engagement across its platforms [19][20]. Financial Technology and Enterprise Services - Revenue from financial technology and enterprise services reached RMB 549.07 billion, a 5% year-on-year increase, benefiting from a recovery in consumer spending and AI-driven enhancements in enterprise solutions [24][26]. - Tencent's cross-border payment services are expanding, with a 45% year-on-year increase in transaction volume, reflecting strong demand from Chinese tourists in Southeast Asia [25][26]. - The integration of AI in cloud services is driving significant growth, with a 60% year-on-year increase in AI-related cloud revenue [25][26]. Future Outlook - Tencent is expected to maintain a compound annual growth rate of over 20% in the gaming sector over the next two years, supported by the launch of cross-platform titles and a strategic push for international revenue [17][27]. - The company's AI strategy is anticipated to enhance its long-term growth potential, with a projected revenue growth of 8%-10% for 2025 [27].

Investment Rating - The investment rating for the company is "Buy" and is maintained [9]. Core Insights - The company continues to expand its capacity, with significant improvements in fee management leading to enhanced potential profitability. The self-operated platform drives GTV growth, and both existing and new housing monetization ratios have improved sequentially. The company is expected to maintain a valuation premium due to its competitive advantages and potential earnings elasticity [2][6]. Summary by Sections Revenue and Profitability - In Q1 2025, the company achieved revenue of 23.3 billion (up 42.4%) and a net profit attributable to shareholders of 0.86 billion (up 98.2%). Adjusted net profit was 1.39 billion (up 0.1%) [6]. - The company’s GTV for Q1 2025 was 843.7 billion (up 34.0%), with existing and new housing businesses growing by 28.1% and 53.0%, respectively [6]. Business Segments Performance - The revenue from existing housing and new housing businesses increased by 20.0% and 64.2%, respectively. Home decoration revenue grew by 22.3%, while rental revenue surged by 93.8% [6]. - The company’s gross profit margin decreased by 4.5 percentage points to 20.7%, but gross profit increased by 17.0% year-on-year [6]. Cost Management and Financial Health - The company effectively managed costs, with selling, general, and administrative expenses decreasing as a percentage of revenue by 7.0 percentage points to 18.1%. The tax rate also decreased by 10.3 percentage points to 38.1% [6]. - As of Q1 2025, the company had cash and cash equivalents totaling 54.8 billion, indicating strong liquidity. The company has prioritized shareholder returns, spending 1.39 billion on share buybacks [6]. Future Outlook - The company is expected to see adjusted net profits of 8.25 billion, 9.02 billion, and 10.03 billion for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 20.2, 18.5, and 16.6 [6]. - The company has room for growth in brokerage business share, and home decoration and rental segments are anticipated to contribute to future growth [2][6].

Investment Rating - The investment rating for the company is "Outperform the Market" [6][24][25] Core Views - The company reported a revenue of 236.5 billion yuan for FY25Q4, representing a year-over-year growth of 7%, with notable performance in e-commerce and cloud services [1][8] - The adjusted EBITA for the quarter was 32.6 billion yuan, up 36% year-over-year, driven by revenue growth and improved operational efficiency [1][8] - The company announced a dividend of $0.25 per share for FY25, emphasizing its commitment to shareholder returns [1][8] Summary by Sections E-commerce Performance - Taobao Group's revenue reached 101.4 billion yuan, growing 9% year-over-year, with a CMR increase of 12% [2][13] - The adjusted EBITA margin for Taobao Group was 41.2%, slightly down by 0.1 percentage points year-over-year [2][14] - The company is focusing on enhancing its instant retail capabilities through the launch of Taobao Flash Purchase [2][14] Cloud Computing - Cloud business revenue was 30.1 billion yuan, reflecting an 18% year-over-year increase, primarily driven by double-digit growth in public cloud services [3][15] - AI-related product revenue continued to grow at triple-digit rates for the seventh consecutive quarter [3][15] - The company maintained its three-year CAPEX plan of 380 billion yuan, with a CAPEX of 24.6 billion yuan for the quarter, up 68% year-over-year [3][15] Financial Projections - Revenue forecasts for FY2026 and FY2027 have been adjusted to 1,052.0 billion yuan and 1,124.6 billion yuan, respectively, reflecting a 2% downward adjustment [4][25] - The adjusted net profit forecasts for FY2026 and FY2027 are 166.9 billion yuan and 182.1 billion yuan, respectively, also reflecting a 3% downward adjustment [4][25] - The company is projected to have a PE ratio of 13 times for FY2026 [4][25] Shareholder Returns - The company repurchased approximately $6 billion worth of shares in the quarter, totaling about 119 billion yuan for the fiscal year [1][24] - The total shareholder return for FY25 is estimated at around 16.5 billion yuan, corresponding to a shareholder return rate of approximately 5% [1][24]

Investment Rating - The report maintains an "Outperform" rating for Gushengtang with a target price of HKD 67.35 per share, indicating a potential upside from the current price of HKD 33.10 [2][5]. Core Insights - The number of medical visits in Q1 2025 increased by 12.7% year-on-year, reaching approximately 1.21 million, although the growth rate has slowed compared to the previous year [3][10]. - The company is expected to see significant performance contributions in 2025 from mergers and acquisitions (M&A), artificial intelligence (AI), and in-hospital preparations [4][11]. Summary by Sections Financial Performance - Revenue projections for 2025 and 2026 are RMB 3.79 billion and RMB 4.63 billion, respectively, reflecting year-on-year growth of 25.3% and 22.2% [5][11]. - Adjusted net profit is forecasted at RMB 480 million for 2025 and RMB 580 million for 2026, with growth rates of 20.6% and 21.0% [5][11]. - The company maintains a gross profit margin of 30.1% and a return on equity (ROE) projected to increase from 11.0% in 2023 to 15.3% in 2026 [5][9]. Growth Drivers - The company has signed equity transfer agreements with four domestic targets in Q1 2025, with an average valuation of 0.8-1x price-to-sales (PS) [4][13]. - An AI initiative is set to launch in July, expected to contribute RMB 30 million to annual performance by creating digital twins of leading TCM specialists [4][13]. - Plans to introduce 10 new in-hospital preparations in 2025, with anticipated revenue exceeding RMB 50 million [4][13]. Market Position - Gushengtang is recognized as a leading domestic chain in traditional Chinese medical services, benefiting from strong brand power and resilient performance [5][11].

Investment Rating - The report assigns a "Buy" rating for China Feihe (06186.HK) for the first time [1]. Core Views - China Feihe is positioned as a leading domestic infant formula brand, with a significant turning point in performance expected in 2024 due to channel reforms and a focus on high-end products [8]. - The company has a strong cash position and plans to increase its dividend payout ratio to 76% in 2024, highlighting its commitment to shareholder returns [8]. - The infant formula industry is anticipated to rebound, with a sustained trend towards high-end products, benefiting China Feihe's strategic focus [8]. Summary by Sections 1. High Dividend and Performance Turning Point - China Feihe is one of the earliest milk powder companies in China, focusing on infant formula and maintaining the top market share [14]. - The company has experienced a significant decline in performance from 2021 to 2023 but is expected to show improvements in 2024, with revenue and net profit projected to grow by 6.2% and 5.3% respectively [20][19]. 2. Strategic Focus on High-End Products - The company has shifted its focus to high-end infant formula products, with the ultra-high-end product line, Star Flying, increasing its revenue share from 22% in 2016 to 75% in 2024 [8][36]. - China Feihe has implemented a robust marketing strategy, achieving the highest brand recognition in the infant formula sector in China [49]. 3. Industry Demand and Market Position - The infant formula market in China is expected to see a marginal recovery, driven by a rebound in birth rates and supportive policies [8]. - China Feihe holds a market share of 17.5% in the infant formula sector, with potential for further growth compared to international competitors [8]. 4. Financial Forecast and Valuation - Revenue projections for China Feihe are set at 221.7 billion, 236.3 billion, and 251.7 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 38.7 billion, 43.0 billion, and 47.3 billion yuan [1]. - The company is currently undervalued compared to peers, with a projected P/E ratio decreasing from 13x in 2025 to 10x in 2027 [8].

Investment Rating - The report maintains an "Outperform the Market" rating for the company [5][70]. Core Insights - In Q1 2025, the company's revenue grew by 42% year-on-year, driven by a recovery in new home transactions and the development of rental services [8][70]. - The company's GTV (Gross Transaction Value) reached 843.7 billion yuan, up 34% year-on-year, with operating income of 23.3 billion yuan [8][70]. - The adjusted net profit for Q1 2025 was 1.39 billion yuan, flat year-on-year, with a net profit margin of 6.0%, down 2.5 percentage points [13][70]. - The company effectively controlled operating costs, with significant reductions in sales, management, and R&D expense ratios [13][70]. Summary by Sections Revenue and Profitability - Q1 2025 revenue was 23.3 billion yuan, a 42% increase year-on-year, with new home business revenue accounting for 35% of total revenue, up 5 percentage points [8][70]. - The adjusted net profit margin decreased to 6.0%, with a gross margin of 20.7%, down 4.5 percentage points [13][70]. Business Segments - The existing home business saw a transaction total of 580.3 billion yuan, a 28% increase year-on-year, but the contribution margin fell to 38.1%, down 6.4 percentage points [22][70]. - The new home business outperformed the market with a transaction total of 232.2 billion yuan, up 53% year-on-year, and a market share increase of 4.5 percentage points to 12.6% [38][70]. - The rental services segment reported a revenue of 5.1 billion yuan, a 94% increase year-on-year, although with a lower contribution margin of 6.7% [48][70]. Financial Forecasts - The company expects adjusted net profits of 8.2 billion yuan and 8.9 billion yuan for 2025 and 2026, respectively, with corresponding earnings per share of 2.28 yuan and 2.46 yuan [70][73]. - The projected PE ratios for 2025 and 2026 are 19.4 and 18.0, respectively [70][73].